SYM Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$284K Buy
543
+81
+18% +$41.5K 0.02% 301
2026
Q2
$229K Buy
+462
New +$205K 0.02% 333

Other funds holding VRTX

SYM Financial's VRTX Position: Q3 2026 in Review

SYM Financial increased its Vertex Pharmaceuticals (VRTX) stake by 18% in Q3 2026, buying an estimated $41.5K and bringing the position to 543 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #301.

SYM Financial first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • SYM Financial held 543 shares of Vertex Pharmaceuticals worth $284K as of Q3 2026.
  • SYM Financial bought 81 Vertex Pharmaceuticals shares in Q3 2026, an estimated $41.5K.
  • Vertex Pharmaceuticals made up 0.02% of SYM Financial's portfolio in Q3 2026, its #301 holding.
  • SYM Financial first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on SYM Financial's 13F filing for Q3 2026, filed 26 Oct 2026.